3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
2
Recruiting
2
Active not recruiting
2
Unknown
1
Suspended
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Polycystic Ovary Syndrome
35
Breast Neoplasms
8
Obesity
5
Neoplasms
5
Prostatic Neoplasms
4
Insulin Resistance
4
Pancreatic Neoplasms
3
Infertility
3
Endometrial Neoplasms
3
Diabetes Mellitus
3
Triple Negative Breast Neoplasms
2
Neuroendocrine Tumors
2
Mouth Neoplasms
2
Metabolic Syndrome
2
Liver Neoplasms
2
Hyperandrogenism
2
Diabetes, Gestational
2
Diabetes Mellitus, Type 2
2
Depression
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Brain Neoplasms
2
Anovulation
2
Weight Loss
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Nodule
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Interventions
Temozolomide
44
Radiotherapy
16
Bevacizumab
9
Surgical Procedures, Operative
5
Carmustine
5
pembrolizumab
4
Lomustine
4
Drug Therapy
4
Sunitinib
3
Standard of Care
3
Radiation
3
Procarbazine
3
Irinotecan
3
Granulocyte-Macrophage Colony-Stimulating Factor
3
Chlorotoxin
3
Carboplatin
3
Blood Specimen Collection
3
tislelizumab
2
fludarabine
2
camrelizumab
2
Radiosurgery
2
Neoadjuvant Therapy
2
Magnetic Resonance Spectroscopy
2
Hyperbaric Oxygenation
2
Ethanol
2
Cyclophosphamide
2
Chemotherapy, Adjuvant
2
CT-322
2
Bortezomib
2
Aminolevulinic Acid
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Glioblastoma
×
Metformin
×
Clear all
NCT02149459
2017-10-27
SMC 0712-13
Sheba Medical Center
Phase 1
Unknown
18 enrolled